静脉胺对创伤后应激障碍 (PTSD) 的影响:系统性审查
Liyang Yin1, Andy Lu1,2, Gia Han Le1,3,4
1Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada.
Acta psychiatrica Scandinavica
|December 1, 2025
概括
静脉注射胺在治疗创伤后应激障碍 (PTSD) 方面表现有前途,多次输液计划和较低剂量可能会提供持续的症状缓解. 神经生物学发现表明,杏仁体的抑制对其治疗效果起着作用.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 创伤后应激障碍 (PTSD) 是一种与创伤暴露有关的虚弱精神健康状况.
- 胺对于PTSD的治疗潜力已得到认可,但其潜在的神经生物学机制需要进一步阐明.
- 本综述批判性地检查了PTSD中胺治疗的临床结果和神经生物学相关性.
研究的目的:
- 为了评估胺在治疗PTSD的临床疗效.
- 研究与胺在PTSD患者的治疗效果相关的神经生物学机制.
主要方法:
- 对随机对照试验进行了主要数据库 (PubMed,OVID) 的系统文献搜索.
- 包括专注于静脉注射胺剂用于PTSD治疗的研究.
- 综合了7项涉及323名参与者的试验数据.
主要成果:
- 在多个试验中,胺的使用显示了PTSD症状的显著改善.
- 多次输液胺剂方案和重复降低剂量 (0.2mg/kg) 与单剂或标准剂量相比,显示出更好的临床结果.
- 观察到症状改善和由中腹前额叶皮层 (vmPFC) 上下抑制杏仁体之间的相关性.
结论:
- 静脉注射胺为PTSD提供了一个潜在的有效治疗选择.
- 未来的研究应该探索将胺与心理治疗结合起来,并进一步研究其在PTSD中缓解症状的机制性途径.
相关概念视频
Post-traumatic Stress Disorder
448
Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
448
Parenteral Anesthetics: Overview
546
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
546
Electroconvulsive Therapy
808
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
808


